Symptomatic pelvic organ prolapse at midlife, quality of life, and risk factors

Obstetrics and Gynecology

Volumn 113, Issue 3, 2009, Pages 609-616

  Fritel, Xavier ^a   Varnoux, Noëlle ^b   Zins, Marie ^b   Breart, Gérard ^b   Ringa, Virginie ^b  

^a Gynécologie and Obstétrique   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DEMOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MIDDLE AGED; MULTIPLE LINEAR REGRESSION ANALYSIS; PARITY; PELVIC ORGAN PROLAPSE; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; SYMPTOMATOLOGY; VAGINAL DELIVERY; COHORT ANALYSIS; DELIVERY; FRANCE; HEALTH SURVEY; SENSITIVITY AND SPECIFICITY; STATISTICAL MODEL; STATISTICS; UTERUS PROLAPSE;

COHORT STUDIES; CROSS-SECTIONAL STUDIES; DELIVERY, OBSTETRIC; FEMALE; FRANCE; HEALTH STATUS INDICATORS; HUMANS; LOGISTIC MODELS; MIDDLE AGED; PREVALENCE; QUALITY OF LIFE; RISK FACTORS; SENSITIVITY AND SPECIFICITY; UTERINE PROLAPSE;

EID: 64249128682     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e3181985312     Document Type: Article

References (38)

1. Rortveit G, Brown JS, Thom DH, van den Eeden SK, Creasman JM, Subak LL. Symptomatic pelvic organ prolapse: prevalence and risk factors in a population-based, racially diverse cohort. Obstet Gynecol 2007;109:1396-403.
2. DuCoudray AM. Abre'ge' de l'art des accouchements. Châ lonssur- Marne (France): Bouchard; 1773.
3. Carlson KJ, Nichols DH, Schiff I. Indications for hysterectomy. N Engl J Med 1993;328:856-60.
4. Olsen AL, Smith VJ, Bergstrom JO, Colling JC, Clark AL. Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol 1997;89:501-6.
5. Shah AD, Kohli N, Rajan SS, Hoyte L. The age distribution, rates, and types of surgery for pelvic organ prolapse in the USA. Int Urogynecol J Pelvic Floor Dysfunct 2008;19:421-8.
6. Goldberg M, Chastang JF, Leclerc A, Zins M, Bonenfant S, Bugel I, et al. Socioeconomic, demographic, occupational, and health factors associated with participation in a long-term epidemiologic survey: a prospective study of the French GAZEL cohort and its target population. Am J Epidemiol 2001;154:373-84.
7. Ringa V, Lede' sert B, Bre' art G. Determinants of hormone replacement therapy among postmenopausal women enrolled in the French GAZEL cohort. Osteoporosis Int 1994;4:16-20.
8. Fritel X, Ringa V, Varnoux N, Fauconnier A, Piault S, Bre' art G. Mode of delivery and severe stress incontinence, a crosssectional study among 2,625 perimenopausal women. BJOG 2005;112:1646-51.
9. Saadoun K, Ringa V, Fritel X, Varnoux N, Zins M, Bre'art G. Negative impact of urinary incontinence on quality of life, a cross-sectional study among women aged 49-61 years enrolled in the GAZEL cohort. Neurourol Urodyn 2006;25:696-702.
10. Fritel X, Ringa V, Varnoux N, Zins M, Bre' art G. Mode of delivery and fecal incontinence at midlife: a study of 2,640 women in the GAZEL cohort. Obstet Gynecol 2007;110:31-8.
11. Jackson S, Donovan J, Brookes S, Eckford S, Swithinbank L, Abrams P. The Bristol Female Lower Urinary Tract Symptoms questionnaire: development and psychometric testing. Br J Urol 1996;77:805-12.
12. Uebersax JS, Wyman JF, Shumaker SA, McClish DK, Fantl JA. Short forms to assess life quality and symptom distress for urinary incontinence in women: the Incontinence Impact Questionnaire and the Urogenital Distress Inventory. Continence Program for Women Research Group. Neurourol Urodyn 1995;14:131-9.
13. Hunt SM, McEwen J, McKenna SP. Measuring health status: a new tool for clinicians and epidemiologists. J R Coll Gen Pract 1985;35:185-8.
14. Bucquet D, Condon S, Ritchie K. The French version of the Nottingham Health Profile. A comparison of items weights with those of the source version. Soc Sci Med 1990;30:829-35.
15. Baessler K, O'Neill SM, Maher CF, Battistutta D. An interviewer- administered validated female pelvic floor questionnaire for community-based research. Menopause 2008;15: 973-7.
16. Doshani A, Teo RE, Mayne CJ, Tincello DG. Uterine prolapse. BMJ 2007;335:819-23.
17. Barber MD, Neubauer NL, Klein-Olarte V. Can we screen for pelvic organ prolapse without a physical examination in epidemiologic studies? Am J Obstet Gynecol 2006;195:942-8.
18. Bradley CS, Nygaard IE. Vaginal wall descensus and pelvic floor symptoms in older women. Obstet Gynecol 2005;106: 759-66.
19. Ghetti C, Gregory WT, Edwards SR, Otto LN, Clark AL. Pelvic organ descent and symptoms of pelvic floor disorders. Am J Obstet Gynecol 2005;193:53-7.
20. Tan JS, Lukacz ES, Menefee SA, Powell CR, Nager CW. Predictive value of prolapse symptoms: a large database study. Int Urogynecol J Pelvic Floor Dysfunct 2005;16:203-9.
21. Ellerkmann RM, Cundiff GW, Melick CF, Nihira MA, Leffler K, Bent AE. Correlation of symptoms with location and severity of pelvic organ prolapse. Am J Obstet Gynecol 2001;185:1332-8.
22. Swift SE. The distribution of pelvic organ support in a population of female subjects seen for routine gynecologic health care. Am J Obstet Gynecol 2000;183:277-85.
23. Samuelsson EC, Victor FT, Tibblin G, Svärdsudd KF. Signs of genital prolapse in a Swedish population of women 20 to 59 years of age and possible related factors. Am J Obstet Gynecol 1999;180:299-305.
24. Fialkow MF, Newton KM, Lentz GM, Weiss NS. Lifetime risk of surgical management for pelvic organ prolapse or urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 2008;19: 437-40.
25. Jelovsek JE, Barber MD. Women seeking treatment for advanced pelvic organ prolapse have decreased body image and quality of life. Am J Obstet Gynecol 2006;194:1455-61.
26. Carley ME, Schaffer J. Urinary incontinence and pelvic organ prolapse in women with Marfan or Ehlers Danlos syndrome. Am J Obstet Gynecol 2000;182:1021-23.
27. Chiaffarino F, Chatenoud L, Dindelli M, Meschia M, Buonaguidi A, Amicarelli F, et al. Reproductive factors, family history, occupation and risk of urogenital prolapse. Eur J Obstet Gynecol Reprod Biol 1999;82:63-67.
28. Jackson SR, Avery NC, Tarlton JF, Eckford SD, Abrams P, Bailey AJ. Changes in metabolism of collagen in genitourinary prolapse. Lancet 1996;347:1658-61.
29. Lazarevski MB. Pelvic morpho-topography and pathogenesis of genital prolapse. Neurourol Urodyn 1999;18:332-3.
30. Mattox TF, Lucente V, McIntyre P, Miklos JR, Tomezsko J. Abnormal spinal curvature and its relationship to pelvic organ prolapse. Am J Obstet Gynecol 2000;183:1381-4.
31. Rinne KM, Kirkinen PP. What predisposes young women to genital prolapse? Eur J Obstet Gynecol Reprod Biol 1999;84: 23-5.
32. Jorgensen S, Hein HO, Gyntelberg F. Heavy lifting at work and risk of genital prolapse and herniated lumbar disc in assistant nurses. Occup Med (Lond) 1994;44:47-9.
33. Mant J, Painter R, Vessey M. Epidemiology of genital prolapse: observations from the Oxford Family Planning Association Study. Br J Obstet Gynaecol 1997;104:579-85.
34. Spence-Jones C, Kamm MA, Henry MM, Hudson CN. Bowel dysfunction: a pathogenic factor in uterovaginal prolapse and urinary stress incontinence. Br J Obstet Gynaecol 1994;101: 147-52.
35. Lukacz ES, Lawrence JM, Contreras R, Nager CW, Luber KM. Parity, mode of delivery, and pelvic floor disorders. Obstet Gynecol 2006;107:1253-60.
36. Risk factors for genital prolapse in non-hysterectomized women around menopause. Results from a large cross-sectional study in menopausal clinics in Italy. Progetto Menopausa Italia Study Group. Eur J Obstet Gynecol Reprod Biol 2000;93:135-40.
37. Hendrix SL, Clark A, Nygaard I, Aragaki A, Barnabei V, McTiernan A. Pelvic organ prolapse in the Women's Health Initiative: gravity and gravidity. Am J Obstet Gynecol 2002; 186:1160-6.
38. DeLancey JO, Trowbridge ER, Miller JM, Morgan DM, Guire K, Fenner DE, et al. Stress urinary incontinence: relative importance of urethral support and urethral closure pressure. J Urol 2008;179:2286-90.